West Pharmaceutical Services, Inc.'s Q2 results highlight growth driven by GLP-1 drugs and high-value products. Click for WST ...

Stevanato inks auto-injector deal to continue drug delivery push By Nick Paul Taylor May 10, 2022 7:30am Stevanato Group Owen Mumford auto-injector drug delivery ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Key Points - Adjusted EPS was $1.84 in Q2 FY2025, beating the $1.51 estimate by 21.9%, and GAAP revenue exceeded expectations by $40.4 million. Proprietary Products sales rose 10.7%, driven by strong ...

West Pharmaceutical Services WST is scheduled to release second-quarter 2025 results on July 24, before the opening bell. In ...

West Pharmaceutical Services, Inc. (NYSE:WST) shares are surging Thursday after the injectable pharmaceutical packaging and ...

West Pharmaceutical saw a 2.3% net sales decline in the second quarter, with a sharper decline in adjusted diluted EPS, but management slightly raised expectations for both measures for the full year.